Article

A surviving case of mitochondrial cardiomyopathy diagnosed from the symptoms of multiple organ dysfunction syndrome

International journal of cardiology (Impact Factor: 6.18). 08/2008; 128(1):e43-5. DOI: 10.1016/j.ijcard.2007.05.072
Source: PubMed

ABSTRACT A 49-year-old female cardiomyopathic patient with heart, hepatic, and renal failure and lactic acidosis was transferred to the intensive care unit without a unifying diagnosis. She was of short stature (145 cm tall), had difficulty in hearing, a past history of complete atrioventricular block, and had received a permanent pacemaker. She had been diagnosed and treated as dilated cardiomyopathy by her primary doctor. Treatment in the intensive care unit for 21 days including plasma exchange, continuous hemodiafiltration, artificial ventilation, and administration of catecholamine, carperitide, and a large amount of coenzyme Q10 (210 mg/day) improved the symptoms. Genetic analysis using mitochondrial DNA from leukocytes and sternocleidomastoid muscle revealed a 3243A>G mutation in the mitochondrial tRNA(Leu (UUR)) gene, which is related to mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). The patient recovered through intensive care and could be discharged from hospital without any sequelae. This case was mitochondrial cardiomyopathy diagnosed from the symptoms of multiple organ dysfunction syndrome. Cardiomyopathy due to the mutation of mitochondrial DNA is not a common disease. However, it should be considered as a possible cause of heart failure.

0 Followers
 · 
95 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondria play critical roles in both the life and death of cardiac myocytes. Pathogenic mitochondrial DNA (mtDNA) mutations leading to mitochondrial dysfunction can cause cardiomyopathies (CMPs). Our aim was to investigate the underlying mitochondrial defect in a patient with hypertrophic cardiomyopathy (hCMP). A detailed clinical and molecular genetic analysis was performed. Total DNA was extracted from lymphocytes in a 14-year-old index male patient with hCMP, preexcitation syndrome, and severe ventricular arrhythmias. Direct sequencing of the PCR fragments was performed. To distinguish deleterious from functionally neutral variants, the ClustalW program, RNAfold software, and PolyPhen algorithm were applied, which predict the pathogenicity of a particular variant by using a set of empirical rules based on the nature of the mutation, the phylogenetic conservation of the variant, and the physicochemical property of the amino acid. The mutational analysis of mtDNA genes revealed four variants. The m.4395A>G transition (C6G) in the MT-TQ gene, which altered an evolutionary conserved nucleotide, with a conservation index of 85.7 % and affected a highly conserved U.G base pair in the secondary structure of MT-TQ. Additionally, the previously reported polymorphisms m.14757T>A, m.15236A>G, and m.15314G>A resulting in the replacement of amino acid residues in the MT-CYB gene were detected. The m.4395A>G variant was scored as possibly pathogenic and may exert a negative effect on heart function to generate hCMP.
    Herz 09/2013; DOI:10.1007/s00059-013-3950-8 · 0.91 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 40-year-old man who was referred to our hospital due to dyspnea was found to have high output cardiac failure on Swan-Ganz catheterization. An endomyocardial biopsy revealed cardiomyocyte hypertrophy with a vacuolar structure consistent with mitochondrial disease (MD). The patient was discharged, then readmitted for high output cardiac failure with hypotension and hyperlactacidemia. Treatment with cardiopulmonary support and hemodiafiltration gradually improved his general condition, although it resulted in ischemic necrosis of the right leg. The hyperlactacidemia completely resolved after amputation, and the high output cardiac failure has not recurred for two years. High output cardiac failure is rare in MD patients and is related to myocardial abnormalities and hyperlactacidemia.
    Internal Medicine 01/2014; 53(4):315-9. DOI:10.2169/internalmedicine.53.1386 · 0.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events (MELAS) is a rare neurodegenerative disorder caused by a mitochondrial DNA point mutation. Besides neurologic and metabolic manifestations, patients sometimes present with pseudo-obstruction of the bowel due to vomiting and anorexia. This report describes the case of a 28-year-old female with MELAS who presented with recurrent superior mesenteric artery syndrome (SMAS). She complained of severe vomiting and malaise, and had a past history of congestive heart failure and SMAS. Severe weight loss following gastrointestinal symptoms was the most important factor leading to bowel obstruction. The patient’s SMAS was improved with conservative treatment, but she expired due to heart and renal failure. This is the first case of MELAS syndrome leading to recurrent SMAS.
    The American journal of emergency medicine 08/2014; 32(8). DOI:10.1016/j.ajem.2014.01.059 · 1.15 Impact Factor